A review discusses the therapeutic potential of the short peptide KED (Vesugen), noting its ability to regulate gene expression related to neurogenesis and cellular aging. The research indicates it may help restore functional activity in neurons and vascular cells by modulating protein synthesis and inhibiting apoptosis.